⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CDTX News
Cidara Therapeutics, Inc.
Cidara Therapeutics Announces BARDA Award to Support Expanded Manufacturing and Clinical Development of CD388, its Non-Vaccine Influenza Preventative Therapeutic
globenewswire.com
CDTX
Cidara Therapeutics Announces First Participants Dosed in Phase 3 ANCHOR Trial Evaluating CD388 for the Prevention of Seasonal Influenza in High-Risk Populations
globenewswire.com
CDTX